Items where authors include "Hagström, E."

Article

Landmesser, U., Lindgren, P., Hagström, E. et al. (7 more authors) (2022) Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden. European Heart Journal - Quality of Care and Clinical Outcomes, 8 (1). pp. 31-38. ISSN 2058-5225

Lindholm, D., Hagström, E., James, S.K. et al. (10 more authors) (2017) Growth differentiation factor 15 at 1 month after an acute coronary syndrome is associated with increased risk of major bleeding. Journal of the American Heart Association, 6 (4). ISSN 2047-9980